Stocks To Buy Now Blog

All posts by Christopher

SRAX Inc. (NASDAQ: SRAX) To Host LD Micro’s 13th Annual Main Event on Sequire Platform, Speakers Include Shaquille O’Neal & Brock Pierce

  • SRAX to host 13th Annual LD Micro Main Event on December 14-15, 2020 via its SRAX Virtual Events SaaS platform
  • Conference will feature over 250 company presentations, interviews include Shaquille O’Neal and 2020 presidential candidate Brock Pierce
  • 2 million+ small-cap investors invited from SRAX’s active investor base
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, will be hosting the 13th Annual LD Micro Main Event on December 14-15, 2020 via its Sequire Virtual Events SaaS platform. Over 250 companies are scheduled to present to a potential audience of over 2 million invited guests. Attendees will have exclusive access to interviews with Shaquille O’Neal and 2020 presidential candidate Brock Pierce along with other influential panelists across the small-cap space. Since being acquired by SRAX, LD Micro – already a leader in small- and micro-cap conferences – has gained access to the largest active base of micro-cap investors in the world at over 2 million and counting. Since its inception in 2006, LD Micro has grown from a newsletter into a prominent portal that provides exclusive intraday information covering North American stocks with market capitalizations between $50 million and $300 million. The LD Micro Main event this year is set to be one of the company’s most ambitious endeavors in its history, set to bring together millions of potential investors with companies in the flourishing micro-cap space. “I think the Main Event will be the first virtual conference this year that is engaging instead of repetitive,” said LD Micro Founder and CEO Chris Lahiji (https://ibn.fm/bAOws). “There have been too many 20-minute PowerPoints, and investors have lost the desire to watch one more of the same thing. We intend to showcase something different.” Besides its all-new presentation format, the conference will be presented on Sequire, SRAX’s SaaS platform that leverages data analytics for public companies. Tailored to the investment industry, Sequire helps public companies unlock valuable data and insights that can be used to create and activate marketing campaigns in order to attract new investors and engage existing shareholders. “With the launch of this virtual conference, we are one step closer to our mission of creating the most comprehensive platform for issuers,” said SRAX Founder and CEO Christopher Miglino. “We believe this conference will be a success for both the investors and the issuers in the Sequire community, and we look forward to the expansion of the LD Micro audience.” Investor relations in recent years have undergone a rapid transformation with the advent of data-based platforms that allow public companies to track their investors’ behaviors and trends. The movement is projected to continue at a rapid pace, positioning SRAX favorably in the investor relations industry, set to radically transform from innovations in the collection and application of investor data. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

Brain Scientific Inc. (BRSF) New Management to Play Key Role in Advancing Commercialization, Growing Revenue

  • BRSF enhances executive team with new strategy, marketing VPs.
  • New market opportunity created with demand for remote EEG testing due to COVID-19.
  • Brain Scientific has developed NeuroCap(TM), a revolutionary, hospital-grade disposable EEG headset.
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, strengthened its executive team with the appointment of two proven sales and marketing figures. The two management additions include Amy Griffith, the new vice president of strategy and business development, who will lead the development of strategic and tactical initiatives (https://ibn.fm/Stz6j), and Stuart Bernstein, the new vice president of marketing, who will be responsible for BRSF’s marketing strategy (https://ibn.fm/yfZYU). The strategic move is designed to drive Brain Scientific’s revenue growth and expand its commercialization programs by leveraging the newly hired key executives’ wealth of experience and knowledge. As a commercial-stage, healthcare company disrupting the brain diagnostics market, Brain Scientific is committed to the rapid deployment of its unique technology, bringing its NeuroCap, a revolutionary hospital-grade disposable EEG headset, to as many patients as possible as quickly as possible. Recent research indicates that more than one-third of coronavirus patients experience neurologic symptoms, a fact that adds greater urgency to the company’s efforts to bring the device to market. The NeuroCap offers fast testing with limited contact between medical staff and infected patients, a vital feature in the pandemic environment. A leader in the development and commercialization of innovative life-changing technologies for patients, Brain Scientific is poised to seize the market opportunity opened up by the demand for remote EEG testing. To support its ambitious plans for the future, BRSF enhanced its executive team with seasoned industry figures with a proven track record of success. As an established sales expert with years of experience in the medical and healthcare industries, including health giants such as GlaxoSmithKline, Griffith is a key addition to the management team. Griffith brings extraordinary credentials to Brain Scientific as the company continues to grow as the leader in routine EEG testing. Her experience in global marketing positioning will be critical to BRSF’s future success. With extensive expertise in developing new business opportunities and implementing effective sales strategies and impressive background in the neurology market, she will focus on ensuring the company is well prepared to execute on its next phase of growth. Bernstein has more than 30 years of industry experience in marketing, sales and start-up leadership at companies in the medical devices and healthcare space. He has acquired a wealth of knowledge and skills ideal for leading Brain Scientific’s marketing strategy and propelling the company’s growth to new heights. Previously a CEO of BioSignal, an EEG medical device company, Bernstein is a proven industry veteran with in-depth knowledge and expertise necessary to implement a successful go to market strategy. Bernstein will work collaboratively with Griffith to implement business strategies that support future growth. Together they are poised to set Brain Scientific on the path of growth, shaping the future of the brain diagnostics space. For more information, visit the company’s website at www.BrainScientific.com. NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

PowerTap, An Investee Company Of Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF), Sets Sights on Developing Hydrogen Fuel Market

  • Clean Power Capital Corp. (formerly known as Organic Flower Investments Group Inc.) has built a successful holding company model with 10 investments in a variety of sectors, and its most recent investment is focused on the developing hydrogen fuel marketplace
  • The state of California, which boasts the world’s fifth-largest economy, is emerging as a hydrogen fuel booster amid global concerns about climate change
  • PowerTap Hydrogen Fueling Corp., an investee company of Clean Power, aims to begin building a 500-station fueling network across the state during the next year before advancing into other parts of the country
  • Researchers at McKinsey & Company are forecasting that the hydrogen economy could generate $140 billion in annual revenue by 2030 and support 700,000 jobs (https://ibn.fm/Ztdj2).
While President Donald Trump’s administration has attempted to move the United States away from global climate change science efforts to boost alternatives to the petroleum fuel standard, the apparent victory of President-elect Joseph Biden (which, in a contested election, will be settled between Dec. 14 and Jan. 6 as electors’ votes are counted (https://ibn.fm/JWII5) signals a new impetus by the nation to advance renewable fuels’ potential. Biden’s acknowledgment in a presidential debate that he intends to promote alternative fuels drew pleased criticism from Trump, who expected states with significant petroleum-based economies to reject the candidate (https://ibn.fm/jowvE). But one of those states — Pennsylvania — provided what appears to be the decisive returns in Biden’s favor (https://ibn.fm/Z1ySI). Independent of the national stance on climate change, the state of California, which has an economy larger than all but four countries worldwide (https://ibn.fm/4WDxr), continues to develop its own interests in renewable-energy fuels, emerging as a potential driver of clean-energy hydrogen-based systems for automobiles. Investment holding company Clean Power Capital (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) sees the developing marketplace as ripe with potential, as evidenced by recent efforts to invest in and provide early-stage financing to businesses aligned with California’s hydrogen fuel market. Clean Power Capital (known prior to November as Organic Flower Investments Group Inc.) currently has 10 investments in a variety of sectors and successfully held nearly C$120 million in investments during the past fiscal year as it turned its attention to an equity investment in PowerTap Hydrogen Fueling Corp. that granted it a 90 percent equity interest (https://ibn.fm/ciw9R). PowerTap Hydrogen Fueling is a technology-developing business determined to build a network of hydrogen fuel stations across California and eventually across the country in a phased development approach, utilizing the company’s onsite steam methane reforming (“SMR”) hydrogen production and dispensing modular units, which have the potential to establish an environmentally cleaner hydrogen fueling process than technologies dependent on a significant amount of electricity to produce hydrogen, and to be more cost effective than offsite-produced hydrogen. PowerTap is aiming for an initial launch of 500 fueling stations in California, co-located at existing gas stations and truck stops and dependent on the necessary agreements for their technology installation. At each stage of development, PowerTap plans to help fund its project through available government financing and credits, in addition to equity, debt and convertible debt offerings. The company expects its planned fueling station network building to begin in the final weeks of this month with initial manufacturing to begin in the first quarter of next year and production to continue throughout the year. From San Diego to San Francisco, hydrogen fueling stations are increasing in number and growing in size as California sets ambitious goals to phase out vehicles that run on fossil fuels and replace them with autos that powered by batteries and hydrogen. The state is providing significant financial incentives to help the fuel alternative develop. “In past cycles, there was always something missing,” Matthew Blieske, Royal Dutch Shell’s global hydrogen product manager, told the New York Times recently (https://ibn.fm/LfseG). “There was a policy missing, or the technology wasn’t quite ready, or people were not so serious about decarbonization. We don’t see those barriers anymore.” A recent study by business and economics researchers at McKinsey & Company estimated that the hydrogen economy could generate $140 billion in annual revenue by 2030 and support 700,000 jobs, and that hydrogen could meet 14 percent of total American energy demand by 2050, according to the report (https://ibn.fm/MkGgd). For more information, visit the company’s website at www.CleanPower.Capital. NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

  • Imagin Medical Inc. uses the standard levels of care for bladder tumor resection and adds advanced technology combined with an FDA-approved imaging agent to display images side-by-side in real-time to provide better cancer visualization, potentially leading to less recurrence
  • Hospitals can use their existing endoscopic equipment, as the company’s technology is compatible with almost every model on the market
  • The i/Blue™ Imaging System can potentially be used for other minimally invasive procedures, accommodating multiple contrast agents and illumination sources
  • Bladder cancer contributes to 4.5% of all new cancers diagnosed and 3% of all cancer-related deaths. It is the sixth most prevalent form of cancer in the United States, with a greater than 50% risk of recurrence
  • The company is led by a management team with experience in this industry, including minimally invasive surgery and medical device implementation
Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures. Its initial focus is on bladder cancer. The company’s first product is the i/Blue Imaging(TM) System, based on advanced optics and light sensors and employing patented ultrasensitive imaging technology. Imagin Medical believes the system can significantly improve surgeons’ ability to visualize and remove cancer cells. Founded in 2016 and headquartered in Boston, Massachusetts, the company works to enhance its market potential by expanding its technology to multiple endoscopic indications, such as laparoscopic, colorectal and thoracic procedures, accommodating multiple contrast agents and illumination sources. i/Blue Imaging(TM) System The conventional method used for visualizing bladder cancer during surgery is an endoscopic procedure called a cystoscopy. This procedure uses white light to illuminate the bladder. White light has been used for decades and is the standard for more than 90% of the market. Blue light cystoscopy uses blue-filtered white light, which addresses the limitations of white light (such as detecting flat tumors and the fine edges that may result in cancerous cells being left behind during removal). Blue light uses a contrast agent that causes cancer cells to fluoresce when illuminated. Surgeons are then able to more effectively visualize and resect the margins of bladder tumors to reduce the risk of recurrence. Notably, the use of the white light is still necessary during a blue-light procedure so that the surgeon can orient their position within the bladder. Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopies. The i/Blue System combines the white and blue light with an FDA-approved imaging agent and simultaneously displays side-by-side images in real-time, without the necessity to switch back and forth between the two images. The i/Blue Imaging System is unlike other methods available on the market today. It is external to the body and can attach to almost any endoscope model currently in use. This way, hospitals adopting Imagin Medical’s technology have the ability to use their current endoscopes without the need to purchase new equipment. Bladder Cancer Prevalence The company’s initial focus is bladder cancer, which is the sixth most prevalent form of cancer in the United States. In 2020, the number of new bladder cancer cases is expected to total 81,400, accounting for 4.5 percent of all new cancers diagnosed. The death rate in 2020 for cancer deaths associated with the bladder is forecast at 17,980, or 3% of all cancer-related deaths (https://ibn.fm/qLi3l). Bladder cancer also has one of the highest recurrence rates among all forms of cancer, leaving about 600,000 people in fear that their cancer will return, according to Imagin Medical. The company is committed to addressing this issue, and i/Blue demonstrations have indicated that the use of both white and blue light can enhance accuracy of detection and removal of cancer cells, potentially lowering recurrence rates. Based on Verified Market Research, the global bladder cancer research market was valued at $3.43 billion in 2018. It is estimated to grow with a CAGR of 4.03% through 2026, resulting in a projected $4.71 billion market (https://ibn.fm/rI7G6). Management Team
  1. James Hutchens is the Chief Executive Officer of Imagin Medical Inc. He is a proven entrepreneur with over 30 years of experience in management in the medical technology industry. Hutchens served as a managing partner with Origin Partners, a $55 million early-stage venture capital fund. He was also the founder and CEO of both Microsurge Inc. (a venture-backed minimally invasive surgical company) and Choice Therapeutics (an advanced wound-care company). He is a former member of the Board of Directors of the Brigham and Women’s and Faulkner hospitals. Hutchins holds a BS in Business Administration from Boston University.
John Vacha is the company’s Chief Financial Officer. He has 20 years of experience in the health care industry. Prior to Medtronic’s acquisition of Intact Medical Corp. in 2017, Vacha was the company’s President, CEO and a board member for seven years. He is a licensed CPA in Massachusetts. Vacha has an MBA and an MS in Accounting from Northeastern University in Boston. He is also a serving member of the Board of Directors at the South Boston Health Center. He currently has two patents in electrosurgical instrumentation. Michael G. Vergano is the Director of Operations of Imagin Medical. He has been the President of The Harvest Group Inc. since 1998, where he has provided consultant services for startups and major corporations. Vergano has over 30 years of experience in the medical device industry. He has held management positions at Microsurge Inc., Ciba Corning Diagnostics and Boston Scientific Corp. He is currently the holder of 11 medical device patents and holds a BS in Mechanical Engineering from Tufts University. Pam Papineau is the company’s Director of Regulatory Affairs. She has over 30 years of experience in quality and regulatory affairs with Boston Scientific, Baxter and Cogentix. She has served as a consultant on various devices including imaging, endoscopy, orthopedic, GI/GU and cardiovascular applications. Papineau has successfully prepared dozens of FDA pre-market and EU submissions to support CE marking of a broad spectrum of medical devices. She is an ASQ Certified Quality Engineer, a Certified Biomedical Auditor, a Certified Quality Auditor and an ISO 13485:2016 Lead Auditor, and she is certified by the Regulatory Affairs Professional Society – U.S., EU and Canada. Papineau works with the company’s legal counsel to prepare pre-submission meetings with the FDA and activities through the regulatory approval process. For more information, visit the company’s website at www.ImaginMedical.com. NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

Knightscope “Robocop” Reduced Crime Dramatically, says California Police Department

  • California police department subscribes to Knightscope K5 robot.
  • K5 combines self-driving technology, robotics and artificial intelligence.
  • K5 robot is a crime-fighting autonomous data machine.
  • Knightscope design makes K5 “people-friendly.”
A recent recruit to California’s Huntington Park Police Department (“HPPD”) didn’t graduate from the Police Academy. Instead, the patrol officer is a product of Silicon Valley company Knightscope. The 400-pound security robot, dubbed “HP RoboCop,” joined the police force in June 2019 and has been patrolling the city of Huntington’s 23-acre Salt Lake Park ever since. Its presence has had a marked effect that may point the way to how policing is carried out in jurisdictions across the nation. After deployment “911” calls fell by 46 percent and citations issued fell by over 68 percent (https://ibn.fm/PKnPg). While Alex Murphy, the original Robocop, was a fearsome figure, HP Robocop is quite the opposite. Its sleek appearance is deliberate. Not to be seen as intimidating or out of place has been the design aim. Just like the cops pounding the beat, HP RoboCop’s presence is expected to deter criminal activity. But the robot’s communications capability, the record of events it can store and its unflagging energy (robots don’t get tired) takes policing to another level. The HP RoboCop is actually Knightscope’s K5 model security robot. It has numerous sensors that make it capable of detecting faces, license plates and even smartphone activity. Once gathered, the data can be checked against security databases. For example, a “white list” of license plates will show vehicles with no known security issues. A “grey list” will show vehicles that have had security issues or that have restricted entry. And a “black listed” vehicle — one that is prohibited — will instantly alert control personnel to possible trouble. Such early alerts could save lives. A review of the mass shootings at Sandy Hook Elementary School in Newtown, Connecticut, led the International Association of Chiefs of Police (“IACP”) to conclude that had police reached the scene just 60 seconds earlier, they could have saved at least 12 more lives than they were able to. Indeed, the Robocop idea took shape after the Sandy Hook tragedy. The K5 is more about reconnaissance than confronting law breakers. Its prime function is to act as the “ears and eyes” of the police force. “The only way to gain accurate intelligence is through eyes and ears,” says Stacy Stephens, Knightscope executive vice president and chief client officer (https://ibn.fm/K95aU). That accurate intelligence is exactly what Knightscope’s K5 security robot provides. The K5, designed for outdoor use, combines self-driving technology, robotics and artificial intelligence to create what Knightscope refers to as a “crime-fighting autonomous data machine” (https://ibn.fm/kNU5x). For indoor use, Knightscope has developed the K1, a stationary robot that can be used at entrance and exit points. The K5 has been warmly welcomed by the Huntington community. Visitors to and workers at Salt Lake Park, where it is deployed, seem reassured by its presence. In fact, the Robocop has gained celebrity status. Shops report an uptick in business as curious sightseers descend on the park to take selfies with the robot. Rather than being scared or irritated by the K5s, humans are delighted by the idea of robot policemen. It may not be too long before a K5 pounds the beat in your neighborhood. For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue “Instant Messaging” button for direct contact with the company CEO. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) New CEO Represents Important Step in Company’s Evolution

  • Daniel Schieber has been appointed GOH CEO, will also serve as director
  • Schieber brings essential skills, experience in capital financing, along with extensive capital markets network
  • Schieber uniquely qualified for new role, significant responsibilities in mining sector
GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canadian junior mining company, has appointed Daniel Schieber as CEO; Schieber will also serve as a director for the company. The appointment took effective in November.  Former CEO David Smith will continue in his role as GoldHaven president and will also be a director. “Mr. Schieber’s appointment as CEO is an important step in the evolution of GoldHaven in its quest to discover and develop potential gold deposits,” said Smith. “Capital financing is absolutely key to achieving this and we feel that Daniel brings the necessary set of skills and experience as well as an extensive capital markets network to achieve this goal.” Schieber comes to his new role uniquely qualified for significant responsibilities in the mining sector. He began his career in metals and mining finance as an analyst for the Stabilitas Group of Funds in 2005 before co-founding Euroscandic International Group, where he raised approximately $350 million in project financing for specific development projects in the mining sector. In the past decade, Schieber also gained experience with Canadian-based farmland investments when he became chief investment officer at Dynamis Capital Corp., which also focuses on long-term, recession-proof investments with emphasis on gold and silver. “I am personally and professionally investing in GoldHaven in order to join Patrick Burns, GOH’s Vice-President Exploration, and the incredible portfolio of assets that he and the GoldHaven team have put together,” said Schieber. “I’m excited to work towards developing these assets’ potential within the gold-rich porphyry systems in the Maricunga Belt of Northern Chile. Further, I believe that this is a phenomenal opportunity and my focus will be to efficiently provide results to our shareholders.” With the CEO appointment, GoldHaven granted to Schieber, pursuant to its 2019 Stock Option Plan, incentive stock options to purchase of 500,000 shares in the capital stock of the company. The options vest immediately from the date of grant and are exercisable on or before Nov. 2, 2023, at a price of $0.42. As a junior exploration company, GoldHaven is active in the Maricunga Gold Belt located in Northern Chile, hosting more than 100Moz of gold, 450Moz of silver and 13Blbs of copper. In addition to its properties in the prolific Maricunga Gold Belt, GOH also operates Canadian projects, including the first phase of the 2020 exploration program on its Adam West property located in Vancouver Island, British Columbia. With key people in place who have decades of experience and successes in the mining industry and the corporate strategy focused on identifying and capitalizing on precious metal projects in mineral-rich districts within stable political jurisdictions, GoldHaven seems in an ideal position to offer the strengths investors tend to look for in uncertain economic times. For more information, visit the company’s website at www.GoldHavenResources.com. NOTE TO INVESTORS: The latest news and updates relating to GHVNF are available in the company’s newsroom at http://ibn.fm/GHVNF

InsuraGuest Technologies, Inc. (TSX.V: ISGI) Further Extends Hospitality Liability Coverage Following Agency Producer Deal with Foundation Risk Partners

  • Foundation Risk Partners is one of the fastest-growing insurance brokerages and consulting firms in the US that uses platforms and services within the commercial, personal, employee, and risk management industries to provide their clients with a pool of resources.
  • The InsuraGuest Hospitality Liability coverage will help reduce the number of smaller claims that Foundation Risk Partners clients make to their general liability providers, which may lower their premiums, decrease risks and generate additional revenue
  • InsuraGuest’s insurtech platform integrates with over 70 property management software platforms. The company is committed to continue expanding its brand and sales footprint
Innovative insurtech provider InsuraGuest Technologies (TSX.V: ISGI) is continuing its efforts to revolutionize the insurance industry by harnessing the power of technology, and more specifically, its proprietary software platform, to deliver digital insurance across multiple sectors. Committed to the idea that insurance should be bought, not sold, the company recently signed another Agent Producer Agreement that would allow it to extend the reach of its novel Hospitality Liability Coverage to more hotel and vacation rental properties. The latest agreement was signed by the company’s wholly owned subsidiary InsuraGuest, Inc. with Foundation Risk Partners, one of the fastest-growing insurance brokerage and consulting firms in the United States, and an industry leader in its own right, dedicated to pushing the boundaries of insurance excellence (https://ibn.fm/D4qrz). The company leverages leading platforms and services in the commercial, personal, risk management and employee benefits sectors, as well as selected partnerships, to provide its customers with pooled resources. According to Foundation Risk Partners Executive Vice President, Southeast Sales, Alan Florez, the brokerage was excited to partner with InsuraGuest Technologies for the benefit of its hotel and resort customers. “The InsuraGuest relationship enhances our comprehensive risk management focus within our hospitality vertical,” Florez added. Under the Agent Producer Agreement, Foundation Risk Partners will begin to provide InsuraGuest’s Hospitality Liability coverage to its U.S. hotel clients. The coverage and platform will allow the transfer of frequent property and medical guest claims to InsuraGuest’s policy, which will significantly reduce risk, decrease premiums and help generate additional revenue for hotel operators. Small property or medical claims currently make up a sizeable portion of hotel claims applied to the general liability policy, leading to higher premium prices. Through InsuraGuest, the risk is transferred from the hotel, by having guests pay a nominal fee per night. These small claims are then paid by InsuraGuest, thus limiting impact on the hotel’s general liability policy. Foundation Risk Partners hotel clients will extend the InsuraGuest Hospitality Liability coverage to every guest, which is activated upon check-in. This activation automatically places the charge for the coverage on their folio or bundles it with the fees associated with the stay. The complete fee for coverage is $4.95 per night. The hotel will get to keep 10% of this, generating extra revenue. InsuraGuest CEO and Chairman Douglas Anderson welcomed the agreement with Foundation Risk Partners, as part of InsuraGuest’s continued drive to expand its brand and sales footprint. The agreement with Foundation Risk Partners came shortly after a similar deal with USI Insurance Services, a leading insurance brokerage which will distribute the Hospitality Liability coverage through its network of more than 7,5000 professional brokers nationwide (https://ibn.fm/KNW4r). These partnerships can help InsuraGuest to further cement its leading position on the fast-growing insurtech market. With technology touching almost every industry worldwide, the insurance industry has been no exception. Valued at $5.48 billion in 2019, the global insurtech sector is expected to reach $10.14 billion by 2025, with a CAGR of 10.8% during the forecast period of 2019-2025 (https://ibn.fm/mRJFQ). This growth offers multiple opportunities to InsuraGuest Technologies in terms of expanding its technology outward to cover a wide range of industries asides from the hospitality sector, reaching a larger audience and creating additional revenue. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

HempFusion Wellness’ Winning Product Line, Distribution Formula Signals Successful IPO

  • HempFusion poised for IPO on Toronto Stock Exchange
  • Company expects to raise $17 million in public markets debut
  • Product portfolio of 46 products
  • Products currently sold in more than 4,000 retail locations across 50 states with a 26,000-store pipeline
  • Hemp-based CBD market expected to reach $22 billion by 2022
If there was ever a winning prescription for a successful initial public offering (“IPO”), HempFusion Wellness seems to have found it. The Denver-based provider to the health and wellness CBD market has a comprehensive product line that appears to meet the needs of anyone between 9 and 90. Its extensive distribution network is testament to the maxim: It’s not who you know but who knows you. The company recently filed for an IPO on the Toronto Stock Exchange (“TSX”). With a proven management team and increasing consumer adoption of CBD and hemp-based products, HempFusion seems set for a dramatic debut to the public markets. When listed, the company will trade under the ticker symbol CBD.U. The HempFusion Wellness portfolio of offerings — currently 46 products — falls into two major categories: CBD/hemp-based and probiotics. The CBD/hemp product line includes remedies to promote healthy sleep, combat enervation and stress, and provide relief for certain specific conditions. All products are manufactured from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s condition-specific OTC products include:
  • OTC Pain Products — The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4% (https://ibn.fm/ZgWD4)
  • OTC Eczema Products — The global dermatitis market is projected to reach $13.6 billion by 2026
  • OTC Acne and Aging/Beauty Products — The global market for beauty and anti-aging products is currently estimated at $1.08 trillion
  • OTC First Aid and Wound-Healing Products — In 2019, the 10 top-selling first aid ointments in the United States generated more than $650 million in sales
  • The hemp-based CBD market is expected to reach $22 billion by 2022
HempFusion Wellness also markets a line of probiotics through its wholly owned subsidiary, Probulin Probiotics. The probiotics sector is a fast-developing area of opportunity, with a market projected to reach $7 billion globally by 2022. HempFusion is hoping its probiotic line will establish relationships that make it easier for retailers which are new to CBD/ hemp to carry such products. HempFusion has filed to complete an IPO on the Toronto Stock Exchange (“TSX”). The company is hoping to raise US$17 million. For more information, visit the company’s website at www.HempFusion.com/corporate-information. NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion

Rritual Superfoods Inc. Fields Powerhouse CPG Lineup to Market Functional Mushrooms

  • Demand for Functional Mushrooms Experiencing CAGR of Over 10 Percent
  • Market Projected to Increase from $23 billion in 2020 to $34 billion by 2024
  • 61% of the Americans Say Healthfulness Significantly Impacts Their Food Purchases
  • Rritual Superfoods Offering Functional Products Based on Chaga, Lion’s Mane and Reishi Mushrooms
  • Company Led by Stellar Consumer Packaged Goods (“CPG”) Executive Cast
Functional foods are fast-rising fare for a growing number of Americans. It’s the same on the world stage, where similar forces are in play. As a result, the functional foods market is projected to continue its current 7.9% CAGR until the year 2025. One sector of the market — functional mushrooms — is growing even faster. Demand for functional mushroom is forecast to increase at a CAGR of more than 10%, from $23 billion in 2020 to $34 billion by 2024. These developments augur well for innovative start-up Rritual Superfoods. The company has developed a suite of health-enhancing “functional” products based on various types of mushrooms. With marketing and distribution initiatives spearheaded by an experienced team of consumer packaged-good (“CPG”) executives, Rritual plans to quickly establish a dominant presence in the fast-developing functional foods market. Much better informed and with higher incomes, 21st-century food shoppers are a great deal more selective than previous generations. In pursuit of a diet that supports wellness, they are shifting their purchases towards functional foods. Paradoxically, the fast food industry, with its overly processed products packed with artificial ingredients, might be partly responsible. Growing awareness of the ills brought on by their menus is spurring the food shopper of today to look for products that not only offer convenience but are conducive to good health. The 2018 Food & Health Survey conducted by the International Food Information Council Foundation found that “61% of the American population say healthfulness has a significant impact on their food and beverage purchases” (https://ibn.fm/UyZQA). Consumers don’t just want food to taste good, they want it to have “function,” where the function is some improvement in physiological or psychological well-being. As a separate consumer sector, functional foods have taken off in the Far East as well. Its origins may be traced back to 1991, when Japan’s Ministry of Health began designating some foods as “foods for specified health uses” (“FOSHU”) (https://ibn.fm/1P3SW). However, functional foods, under the label of “fortified foods,” have been available for decades. In the United States, iodine was first added to salt in 1924 in an attempt to alleviate incidences of goiter. And in the early 1930s, cow’s milk began to be fortified with vitamin D to combat rickets, which causes poor bone development and deformities in children. Functional mushrooms predate even these developments. They have been used as health aids for over two millennia. To name just a few, there’s turkey tail, an immune booster; chaga, an immune booster and anti-inflammatory; lion’s mane, a booster for the brain and immune system;  reishi, another immune booster, which also helps to cope with anxiety; and Cordyceps, an energy booster. Ranked as a top-10 food trend by Whole Foods, functional mushrooms are typically consumed in a dry, powdered form. They can be combined with adaptogen herbs, which help the body handle stress, for unique benefits. With a long shelf life when correctly processed and packaged., functional mushrooms are set to transform the functional food industry. Since the industry is in an early stage of development, no market leader has emerged. This presents opportunity the Rritual management are poised to seize. The team is headed by CEO David Kerbel, who brings more than 30 years of experience at a senior level in retail, brokerage and CPG. David was an early Senior Vice President of Celsius Holdings, which currently trades on the Nasdaq (CELH). Warren Spence is chief operating officer. Spence has occupied senior positions at Red Bull and Olivieri during his 25-year career in the food and beverage industry. Rounding out the lineup of top CPG operatives is VP of USA sales Sarton Molnar-Fenton, a former executive of Danone and Nestlé. For more information, visit the company’s website at https://investors.wearerritual.com. Mental Fitness Is a Daily Ritual NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at http://ibn.fm/Rritual

InsuraGuest Technologies, Inc. (TSX.V: ISGI) Expanding Brand Recognition and Growth Through Agent Producer Agreement with USI Insurance Services

  • USI is a brokerage and consulting firm with over 7,500 professional and nationally networked brokers that will expand the InsuraGuest brand exposure
  • The global insurtech market is expected to reach $10.14 billion by 2025 with a CAGR of 10.8% – up from $5.48 billion in 2019
  • InsuraGuest is currently ahead of its growth model’s expectations
  • The proprietary insurtech platform can integrate with over 70 property management systems for easy implementation
Innovative insurtech provider InsuraGuest Technologies (TSX.V: ISGI), via wholly-owned subsidiary InsuraGuest Inc., recently signed an Agent Producer Agreement with USI Insurance Services (“USI”), a leading United States insurance brokerage and consulting firm. Under the agreement, USI will distribute InsuraGuest’s innovative Hospitality Liability coverages through its network of more than 7,500 professional brokers nationwide (https://ibn.fm/CsfBt). This agreement with USI continues a series of partnerships that InsuraGuest has been signing lately to expand the reach of its insurtech platform and insurance services. “InsuraGuest continues to attract and execute exciting relationships with nationally recognized leaders in the insurance industry,” CEO and Chairman Douglas Anderson said. “Our sales and outreach program, paired with our expansive broker networks, allow us to expand our customer base and grow our brand recognition more quickly than our original growth models indicated.” According to the CEO, this growth avenue will not only increase sales dramatically and provide true nationwide coverage, but it will increase shareholder value as a result. These partnerships can help InsuraGuest to further cement its leading position on the fast-growing insurtech martket. With technology touching almost every industry worldwide, the insurance industry has been no exception. Valued at $5.48 billion in 2019, the global insurtech sector is expected to reach $10.14 billion by 2025, with a CAGR of 10.8% during the forecast period of 2019-2025 (https://ibn.fm/3MqKV). This growth offers multiple opportunities to InsuraGuest, a company committed to harnessing the power of technology to reinvent the insurance industry. With a proprietary software platform that delivers digital insurance to multiple sectors across various industries, the company aims to revolutionize the way insurance is delivered based on the idea that insurance should be bought and not sold. InsuraGuest’s proprietary insurtech platform and liability coverages provide a viable solution to the high frequency of claims that hotel and vacation rental operators are facing and that are frequently applied to the general liability policy, resulting in higher risk exposure and higher premium prices for the property owners. InsuraGuest’s solution transfers the risk from the hotel and vacation rental operators by having guests pay for the coverage at a nomrinal fee per night. Then, all small claims are paid by InsuraGuest, thus keeping them off the property owner’s general liability policy. InsuraGuest Hospitality Liability covers incidentals such as accidents, in-room property damage, accidental medical, death, or dismemberment, or theft claims, which can be filed through the Hospitality Liability coverages instead of the general liability coverage. In addition to reduced risk and lower premiums, the benefits of incorporating the insurtech platform include affordable supplemental insurance options at affordable pricing, improved guest experiences, and prompt compensation. In the last decade, approximately $16.5 billion has been invested in insurtech. The pressure for change and innovation within the insurance market continues to increase. InsuraGuest has been riding the wave of technological insurance innovation within the digital sector but has been expanding outward, offering insurtech options to a wider audience and creating additional revenue streams. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

From Our Blog

Nasdaq Private Market COO Andrew Krochulick on Getting In Before the Story Is Public

November 13, 2026

Private markets were a featured topic at Stocktoberfest presented by Tradr ETFs, held in New York City from October 5 to 7. In the fireside chat “Private Markets: Getting In Before the Story Is Public,” Andrew Krochulick, COO of Nasdaq Private Market, joined Stocktwits Founder and CEO Howard Lindzon on stage at City Winery on […]

Rotate your device 90° to view site.